[TNGX] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
07-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 19.51%
YoY- 16.69%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 6,471 5,431 10,732 14,598 5,766 6,411 6,920 -4.36%
PBT -37,874 -30,716 -22,240 -20,646 -28,008 -29,009 -29,050 19.32%
Tax 40 47 23 64 -2,278 51 -873 -
NP -37,914 -30,763 -22,263 -20,710 -25,730 -29,060 -28,177 21.85%
Tax Rate - - - - - - - -
Total Cost 44,385 36,194 32,995 35,308 31,496 35,471 35,097 16.92%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -585.91 -566.43 -207.45 -141.87 -446.24 -453.28 -407.18 27.42%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.35 -0.32 -0.23 -0.23 -0.29 -0.33 -0.32 6.15%
EPS Diluted -0.35 -0.32 -0.23 -0.23 -0.29 -0.33 -0.32 6.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.